Inhibitex to Host Conference Call to Report Third Quarter 2009 Financial Results on November 6, 2009
October 27 2009 - 10:01AM
Business Wire
Inhibitex, Inc. (NASDAQ: INHX) announced today that it will host
a conference call on Friday, November 6, 2009 at 9:00 a.m. EDT to
review the Company’s financial results for the third quarter ended
September 30, 2009 and provide an update on recent corporate
developments. The Company will issue a press release regarding its
financial results on the same day, prior to the conference
call.
Webcast Information
To access the conference call, please dial 877-407-8033
(domestic) or 201-689-8033 (international). A replay of the call
will be available from 11:00 a.m. EDT on November 6 until December
6, 2009 at midnight. To access the replay, please dial 877-660-6853
(domestic) or 201-612-7415 (international) and reference the
account # 286 and the conference id # 336098. A live audio webcast
of the call and the archived webcast will be available in the News
and Events section of the Inhibitex website at
http://www.inhibitex.com.
About Inhibitex
Inhibitex, Inc., headquartered in Alpharetta, Georgia, is a
biopharmaceutical company focused on developing products to treat
serious infectious diseases. The Company’s pipeline includes
FV-100, its clinical-stage nucleoside analogue in Phase II
development for the treatment of herpes zoster (shingles), as well
as INX-189, an HCV nucleotide polymerase inhibitor in preclinical
development. Inhibitex has also licensed the use of its proprietary
MSCRAMM® protein technology to Wyeth for the development of
staphylococcal vaccines.
Inhibitex® and MSCRAMM® are registered trademarks of Inhibitex,
Inc. For additional information about the Company, please visit
www.inhibitex.com.
Inhibitex, Inc. (MM) (NASDAQ:INHX)
Historical Stock Chart
From Jun 2024 to Jul 2024
Inhibitex, Inc. (MM) (NASDAQ:INHX)
Historical Stock Chart
From Jul 2023 to Jul 2024